Ectopic pregnancy is defined as the implantation of a developing blastocyst outside the normal endometrial cavity of the uterus2,5. While the vast majority implant within the anatomical subdivisions of the fallopian tube (ampulla, isthmus, infundibulum, or interstitium), extrauterine implantations can also occur in the cervix, ovary, scar of a previous Caesarean section, or within the peritoneal cavity. Accounting for approximately 1% to 2% of all reported pregnancies, ectopic gestation remains a leading cause of pregnancy-related maternal morbidity and mortality during the first trimester3,4,5. Because clinical presentations frequently mimic other acute pelvic pathologies, a high index of clinical suspicion coupled with rapid diagnostic evaluation utilizing transvaginal ultrasonography and serial serum quantitative beta-human chorionic gonadotropin ($\beta$-hCG) assays is essential to prevent catastrophic tubal rupture and life-threatening haemorrhage3,4,6.
1. Etiology & Risk Factors
- Tubal Anatomical Damage & Pathology: Prior pelvic inflammatory disease (PID), particularly infections secondary to Chlamydia trachomatis or Neisseria gonorrhoeae, causes endosalpingeal destruction, ciliary loss, and luminal scarring. A history of previous ectopic pregnancy increases recurrence risk 10-fold due to underlying tubal dysfunction4,7.
- Previous Pelvic or Tubal Surgery: Tubal reconstructive surgeries, prior tubal sterilisation procedures, adhesiolysis, and prior Caesarean deliveries significantly alter normal tubal peristalsis and anatomical patency4,7.
- Assisted Reproductive Technology (ART) & Hormonal Factors: In vitro fertilisation (IVF) and ovulation induction therapies increase ectopic pregnancy rates, partly due to high estrogen/progesterone milieus affecting tubal smooth muscle motility and embryo transfer placement dynamics. Current cigarette smoking is an established independent dose-dependent risk factor, altering ciliary beat frequency and tubal immunology4,7.
- Contraceptive Failures: Intrauterine device (IUD) usage overall decreases absolute pregnancy risk; however, if conception occurs with an in-situ IUD (copper or levonorgestrel-releasing), the proportion of pregnancies that are ectopic is substantially increased4,7.
2. Pathophysiology
Normal intrauterine implantation requires timed transit of the fertilized ovum through the fallopian tube, culminating in blastocyst hatching and attachment to a hormonally primed endometrial decidua. In ectopic pregnancy, structural abnormalities of the tubal wall—such as impaired ciliary transport, muscular dysmotility, or luminal diverticula—delay or arrest blastocyst migration. Consequently, the embryo implants prematurely onto the tubal mucosa2,4.
Unlike the thick, highly vascularized uterine endometrium, the tubal mucosa lacks a robust submucosal decidual layer. As trophoblastic invasion proceeds, fetal villi directly erode into the muscularis propria and underlying blood vessels of the thin tubal wall. This uncontained invasion leads to localized microhaemorrhages, progressive distension, and subsequent structural failure of the fallopian tube. If unaddressed, increasing trophoblastic mass and vascular erosion precipitate tubal rupture, resulting in massive intraperitoneal haemorrhage, haemoperitoneum, and acute hypovolaemic shock3,5.
3. Clinical Presentation & Classic Clinical Signs
- History & Cardinal Symptoms: The classic triad consists of secondary amenorrhoea (typically 6 to 8 weeks after the last menstrual period), followed by abnormal, irregular vaginal bleeding (spotting or dark brown discharge) and acute lower abdominal or unilateral pelvic pain. Patients may report sharp, stabbing iliac fossa pain radiating to the back or pelvis. If intraperitoneal rupture and significant haemoperitoneum occur, irritation of the subdiaphragmatic phrenic nerve causes classic referred shoulder-tip pain (Aarons sign)1,2,5.
- Physical Examination & Named Clinical Signs: Vital sign abnormalities range from normal in early stable cases to tachycardia, tachypnoea, hypotension, and orthostatic collapse in ruptured cases with severe haemodynamic instability. Abdominal examination reveals localized tenderness, rebound tenderness, and guarding in lower quadrants. Bimanual pelvic examination elicits marked cervical motion tenderness (CMT) and adnexal tenderness. A palpable adnexal mass may be identified in slender patients, though bimanual palpation must be performed with extreme gentleness to avoid provoking tubal rupture3,6.
4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)
| Diagnostic Modality / Test | Expected Clinical & Radiological / Laboratory Finding |
|---|---|
| Gold-Standard Investigation | Transvaginal Ultrasound (TVUS) demonstrating an empty uterine cavity in the presence of a positive serum pregnancy test, combined with an extrauterine adnexal mass, gestational sac with yolk sac/embryo ('tubal ring sign'), or free fluid in the Pouch of Douglas1,4. |
| Laboratory Panel | Quantitative serum $\beta$-hCG showing a suboptimal rise (less than 63% increase over 48 hours in early non-viable or ectopic pregnancies, compared to normal intrauterine doubling). Serum progesterone levels below 5 ng/mL strongly suggest non-viable or ectopic pregnancy, while levels above 20 ng/mL strongly correlate with a normal intrauterine pregnancy. Complete Blood Count (CBC) to monitor haemoglobin/haematocrit and blood typing/cross-matching (Rh status for anti-D immunoglobulin administration if Rh-negative)3,4. |
| Imaging / Radiology (X-ray, US, CT, MRI) | TVUS is the primary imaging modality. Colour Doppler interrogation typically demonstrates a high-velocity, low-impedance 'ring of fire' vascular flow pattern surrounding the ectopic adnexal mass. Pelvic CT or MRI are rarely utilized primarily unless evaluating complex atypical presentations or acute non-obstetric surgical abdomens3,5. |
| ECG / Histopathology / Procedural | Diagnostic dilation and curettage (D&C) or endometrial suction biopsy may be performed if TVUS shows an empty uterus and non-diagnostic adnexa, combined with abnormal $\beta$-hCG plateaus. Histopathological identification of chorionic villi in uterine curettage specimens rules out ectopic pregnancy (excluding rare heterotopic pregnancies), whereas an absence of chorionic villi (along with Arias-Stella reaction in decidualized endometrium) mandates continued suspicion for ectopic gestation. Diagnostic laparoscopy remains the surgical gold standard for direct visualization and definitive management3,5. |
5. Staging, Classification & Clinical Scoring Systems
| Criterion / Stage / Score Component | Clinical Threshold, Points & Management Implication |
|---|---|
| Haemodynamic Stability Status | Stable patients are candidates for medical or conservative surgical management; unstable patients (hypotension, tachycardia, peritoneal signs, active internal haemorrhage) require immediate emergency surgical intervention and fluid resuscitation2,6. |
| Serum $\beta$-hCG Thresholds | $\beta$-hCG levels $< 1500$ to $5000\text{ IU/L}$ with an unruptured adnexal mass $< 35\text{ mm}$ and absent fetal cardiac activity are suitable for single-dose Methotrexate protocol. Levels $> 5000\text{ IU/L}$ or presence of embryonic cardiac motion significantly lower methotrexate efficacy, favouring primary surgical treatment2,6. |
| Anatomical Site Classification | Tubal ectopic (ampullary [most common], isthmic, infundibular, interstitial/cornual), ovarian, abdominal, cervical, or Caesarean scar ectopic. Interstitial and cervical pregnancies carry significantly higher risks of massive, catastrophic maternal haemorrhage due to abundant local vascular supply. |
| Expectant Management Criteria | Asymptomatic or minimally symptomatic patients with spontaneously declining serum $\beta$-hCG titers and no ultrasound evidence of rupture may be managed expectantly with serial hCG monitoring until complete resolution (< 5 IU/L)3,6. |
6. Differential Diagnosis
| Differential Condition | Distinguishing Clinical, Biochemical & Imaging Features |
|---|---|
| Normal Intrauterine Pregnancy (IUP) | Positive pregnancy test with normal early symptoms. TVUS demonstrates an intrauterine gestational sac (and yolk sac/embryo) with normal escalating serial $\beta$-hCG titers (doubling every 48 hours). |
| Early Pregnancy of Unknown Location (PUL) | Positive serum pregnancy test with an empty uterine cavity and no adnexal mass or free fluid on TVUS. Requires serial $\beta$-hCG tracking and repeat scanning in 48–72 hours to differentiate early IUP, complete/incomplete abortion, or resolving ectopic pregnancy4. |
| Spontaneous Abortion (Miscarriage / Threatened or Complete) | Vaginal bleeding and cramping abdominal pain with a positive pregnancy test. TVUS reveals an irregular gestational sac, low or falling $\beta$-hCG titers, or complete evacuation of the uterine cavity confirmed by histology. |
| Pelvic Inflammatory Disease (PID) / Tubo-Ovarian Abscess (TOA) | Lower abdominal/pelvic pain, fever, purulent cervical discharge, and leukocytosis. Serum $\beta$-hCG is negative. Pelvic ultrasound reveals complex adnexal masses or fluid-filled fallopian tubes without an intrauterine or extrauterine gestational sac. |
| Corpus Luteum Cyst / Ruptured Ovarian Cyst | Acute unilateral pelvic pain often occurring mid-cycle or in early pregnancy. Serum $\beta$-hCG may be negative or positive if pregnant. TVUS demonstrates a simple or complex corpus luteum cyst with internal vascularity, sometimes accompanied by benign physiological pelvic fluid, but no distinct extrauterine gestational sac. |
7. Management & Treatment Protocol
- Initial Stabilization & Resuscitation: Assess airway, breathing, and circulation (ABCs) immediately. Establish large-bore intravenous access (16-gauge or 18-gauge), initiate crystalloid fluid resuscitation, obtain urgent type and cross-match for packed red blood cells, and request immediate surgical consultation if the patient exhibits haemodynamic instability, peritoneal signs, or signs of rupture2,6.
- First-Line Medical / Pharmacological Therapy (with exact adult dosing): Methotrexate (MTX) is a folic acid antagonist used in haemodynamically stable, unruptured ectopic pregnancies with $\beta$-hCG $< 1500–5000\text{ IU/L}$, adnexal mass diameter $< 35\text{ mm}$, and absence of embryonic cardiac activity.
- Single-Dose Regimen: Methotrexate 50 mg/m² body surface area administered as a single intramuscular (IM) injection on Day 1. Serum $\beta$-hCG levels are measured on Day 4 and Day 7. A decline of $\ge 15\%$ between Day 4 and Day 7 indicates successful treatment; follow weekly until undetectable. If the $\beta$-hCG decline is $< 15\%$, a second dose of methotrexate (50 mg/m² IM) may be administered, or surgical intervention considered.
- Contraindications: Absolute contraindications include intrauterine pregnancy, breastfeeding, immunodeficiency, active pulmonary disease, peptic ulcer disease, hepatic/renal dysfunction, known hypersensitivity, or haemodynamic instability/signs of rupture2,6.
- Surgical / Interventional Indications: Indications for primary surgical management include haemodynamic instability, signs of tubal rupture, $\beta$-hCG $> 5000\text{ IU/L}$, presence of embryonic cardiac activity, patient intolerance or contraindications to methotrexate, or failure of medical therapy. Laparoscopy is the surgical approach of choice.
- Salpingectomy: Complete removal of the affected fallopian tube; indicated if the tube is severely damaged, bleeding uncontrollably, if future fertility is not desired, or if there is a history of recurrent ectopic pregnancy in the same tube.
- Salpingostomy: Linear incision along the antimesenteric border of the tube to remove the ectopic conceptus while preserving tubal architecture; considered in patients desiring future fertility who have an unruptured ectopic pregnancy and a healthy contralateral tube2,6.
8. Complications & Prognosis
- Acute Complications: Tubal rupture leading to massive intraperitoneal haemorrhage, profound hypovolaemic shock, disseminated intravascular coagulation (DIC), emergency laparotomy, and potential maternal death. Anaesthetic and surgical risks associated with emergency interventions also contribute to morbidity3,5.
- Long-Term Morbidity & Prognosis: Chronic pelvic pain, intrauterine adhesions, pelvic scarring, psychological distress, depression associated with pregnancy loss, and an increased future risk of recurrent ectopic pregnancy (approx. 10%) or subsequent tubal factor infertility3,5. Overall maternal survival with prompt modern diagnostic pathways and timely intervention is excellent, though future reproductive potential depends heavily on the extent of initial tubal damage and the therapeutic modality employed.
